FindTrial
Sign In

Construction of risk prediction model for axillary sentinel lymph node metastasis of breast cancer based on percutaneous contrast-enhanced ultrasound

Construction of risk prediction model for axillary sentinel lymph node metastasis of breast cancer based on percutaneous contrast-enhanced ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089650
Enrollment
Unknown
Registered
2024-09-12
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Observation group:None

Sponsors

Wenzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Early invasive breast cancer; 2. Single lesion; 3. Tumor =5cm; 4. Imaging examination did not indicate axillary lymph node metastasis or fine needle puncture results of axillary lymph nodes were negative.

Exclusion criteria

Exclusion criteria: inflammatory breast cancer, breast cancer during pregnancy, preoperative neoadjuvant chemotherapy, history of axillary surgery and radiotherapy, history of sulfur hexafluoride allergy, histological or cytological confirmation of axillary lymph node tumor involvement.

Design outcomes

Primary

MeasureTime frame
Type of lymph node enhancement;—

Countries

China

Contacts

Public ContactJian Yu

Wenzhou Central Hospital

791326538@qq.com+86 158 6871 9024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026